NASDAQ
Crescita Therapeutics Inc. (CRRTF) has a price/fcf ratio of 12.03x as of Tuesday, May 26, 2026. This represents a 935.16% increase compared to its 12-month average of -1.44x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.